uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 14, 2021

Maker of Care by Design CBD Settles Charges of Unsupported Claims

On May 5, 2021, Cannacraft, Inc., maker of Care by Design CBD products, agreed to pay $250,000 in civil penalties and $25,000 in investigative costs as part of a settlement of a civil action that charged the company made unsupported claims that its products could treat cardiovascular disease, cancer, Alzheimer's disease and other serious conditions.

The settlement was announced by the Sonoma County District Attorney's Office, which is part of the California Food, Drug, and Medical Device Task Force ("Task Force"). The complaint alleged that Cannacraft made statements about its CBD products on its website (,) that are not supported by competent and reliable scientific evidence, such as "Cannabidiol can change gene expression and remove beta amyloid plaque, the hallmark of Alzheimer's, from brain cells." and "Scientific and clinical studies have shown that CBD could be therapeutic for many conditions, including chronic pain, cancer, anxiety, diabetes, epilepsy, rheumatoid arthritis, PTSD, sleep disorders, alcoholism, cardiovascular disease, antibiotic-resistant infections, and neurological ailments."

"The Sonoma County District Attorney's Office is proud to be part of this important Task Force that protects consumers from false and misleading advertising in the sale of food, drugs and medical devices, including cannabis and CBD products, "Sonoma County District Attorney Jill Ravitch stated in a news release about the settlement.

Cannacraft a licensed cultivator and manufacturer of cannabis products based in Sonoma County, California. According to the news release, the company worked cooperatively to implement changes to its advertising.

See ConsumerLab's CBD & Hemp Extract Supplements, Lotions, and Balms Review for tests of related products.

For more information, use the link below.

Cannacraft, INC., Settles False Advertising Claim for CBD Products

See Related Recalls and Warnings

FDA Warns Five Sellers of CBD for Claims of Treating Arthritis, Alzheimer's and More

CBD Seller Warned for Drug and COVID-19 Claims

Natures CBD Oil Distribution Warned for Joint Pain Claims